期刊文献+

人端粒酶逆转录酶干扰增强肿瘤坏死因子相关的凋亡诱导配体诱导肝癌细胞凋亡的机制

Mechanisms of human telomerase reverse transcriptase RNAi which increases hepatocellular carcinora cell apoptosis induced by TRAIL
原文传递
导出
摘要 目的探讨人端粒酶逆转录酶(hTERT)干扰增加肿瘤坏死因子相关的凋亡诱导配体(TRAIL)诱导肝癌HepG2和SMMC7721细胞凋亡的分子机制。方法采用膜联蛋白V/碘化丙锭染色的流式细胞术方法检测细胞凋亡;采用Western blot方法检测凋亡相关蛋白Procaspase-8、-9、-3及Bax、Bcl-2和hTERT表达;采用端粒重复扩增法和端粒数量和长度测定法检测端粒酶活性和端粒长度。结果hTERT干扰显著增加TRAIL诱导的肝癌细胞凋亡。100ng/ml TRAIL作用24h后,HepG2细胞凋亡率由5.53%增加至10.35%;SMMC 7721细胞凋亡率由14.73%增加至77.24%。hTERT干扰明显增加Procaspase-8、-9和Bcl-2表达,显著降低Bax表达,明显促进TRAIL作用后Procaspase-8、-9、-3活化,并且hTERT干扰后端粒酶活性显著降低,端粒长度明显缩短,然而对照细胞与未转染细胞相比各指标均无明显变化。结论hTERT干扰明显增加TRAIL诱导的肝癌细胞凋亡,其机制可能与Procaspase-8、-9表达增加,端粒酶活性降低和端粒长度缩短有关,而与Bcl-2和Bax表达无关。 Objective To investigate the mechanisms for human telomerase reverse transcdptase (hTERT) RNA interference (RNAi) in increasing hepatocellular carcinoma cell apoptosis induced by TNF- related apoptosis-inducing ligand (TRAIL). Methods Cell apolStosis was identified by flow cytometry analysis after annexin V/PI double staining. Expression of apoptosis-related proteins, procaspase-8, -9, -3, Bax, Bcl-2 and hTERT, were identified by Western blotting analysis; telomerase activity and telomere length were detected by telomeric repeat amplification protocol (TRAP) and telomere amount and length assay (TALA) methods. Results Hepatocellular carcinoma cell apoptosis induced by TRAIL were all significantly increased by hTERT RNAi (P 〈 0.05). For example, apoptosis rates were enhanced from 5.53% (untransformed) to 10.35% (transformed) in HepG 2 cells and from 14.73% to 77.24% in SMMC 7721 cells after being treated by 100 ng/ml TRAIL for 24 h. Moreover, activation of procaspase-8, -9 and -3 in transformed cells after being treated by TRAIL were all significantly raised (P 〈 0.05) in a dose-dependent manner. The expression of procaspase-8, -9 and Bcl-2 were effectively augmented (P 〈 0.05), but expressions of Bax and hTERT were strikingly decreased (P 〈 0.05). Meanwhile, telomerase activity was apparently suppressed and telomere length was markedly shortened (P 〈 0.05). There were no remarkable differences in these effects between control cells and the untransformed cells (P 〉 0.05). Conclusion Enhanced cell apoptosis induced by TRAIL through hTERT RNAi may be related to up-regulation of procaspase-8 and -9 expressions. However the down-regulation of hTERT expression, reduced telomerase activity and shortened telomere length may not be related to expressions of Bcl-2 and Bax.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2007年第1期32-36,共5页 Chinese Journal of Hepatology
基金 全军“十五”科研基金(01MA172)
关键词 肝细胞 细胞凋亡 RNA干扰 逆转录酶 人端粒 Carcinoma, hepatocellular Apoptosis RNAi Telomerase reverse transcriptase
  • 相关文献

参考文献11

  • 1Kamradt MC,Lu M,Werner ME,et al.The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3.J Biol Chem,2005,280:11059-11066.
  • 2Ehrhardt H,Fulda S,Schmid I,et al.TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.Oncogene,2003,22:3842-3852.
  • 3Mattson MP,Fu W,Zhang P.Emerging roles for telomerase in regulating cell differentiation and survival:a neuroscientist's perspective.Mech Ageing Dev,2001,122:659-671.
  • 4Dudognon C,Pendino F,Hillion J,et al.Death receptor signaling regulatory function for telomerase:hTERT abolishes TRAIL-induced apoptosis,independently of telomere maintenance.Oncogene,2004,23:7469-7474.
  • 5张汝钢,房殿春,罗元辉,郭丽萍.人端粒酶逆转录酶干扰对肿瘤坏死因子相关凋亡诱导配体诱导肝癌细胞凋亡的影响[J].中华肝脏病杂志,2006,14(6):435-440. 被引量:8
  • 6张汝钢,房殿春,闫秀英,罗元辉,帖君.hTERT干扰真核表达载体的构建及鉴定[J].胃肠病学和肝病学杂志,2005,14(5):444-447. 被引量:5
  • 7Kim NW,Piatyszek MA,Prowse KR,et al.Specific association of human telomerase activity with immortal cells and cancer.Science,1994,266:2011-2015.
  • 8Gan Y,Engelke KJ,Brown CA,et al.Telomere amount and length assay.Pharm Res,2001,18:1655-1659.
  • 9Mo Y,Gan Y,Song S,et al.Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.Cancer Res,2003,63:579-585.
  • 10Gonzalez-Suarez E,Goytisolo FA,Flores JM,et al.Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-methyl-N-nitrosourea.Cancer Res,2003,63:7047-7050.

二级参考文献22

  • 1郑素军,夏云,任红,钟森,杨英,陶鹏,王升启.端粒酶逆转录酶小干扰RNA对肝癌细胞的体外抑制作用[J].中华肝脏病杂志,2004,12(9):530-533. 被引量:10
  • 2张汝钢,房殿春,闫秀英,罗元辉,帖君.hTERT干扰真核表达载体的构建及鉴定[J].胃肠病学和肝病学杂志,2005,14(5):444-447. 被引量:5
  • 3萨姆布鲁克J 拉塞尔DW 黄培堂 王嘉玺 朱厚础 译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.2-140.
  • 4Masutomi K, Yu E Y, Khurts S, et al. Telomerase Maintains Telomere Structure in Normal Human Cells. Cell,2003,114(2):241-253.
  • 5Smith L-L, Coller -H-A, Roberts -J-M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat-Cell-Biol,2003,5 (5): 474-479.
  • 6Vulliamy T,Marrone N .Goldman F.et al .The RNA component of telomerase is mutated in antosomal dominant dyskeratosis congenita. Nature,2001,413(6854): 432-435.
  • 7Yamada O, Akiyama M, Kawauchi K, et al. Overexpression of telomerase confers a survival advantage through suppression of TRF1 gene expression while maintaining differentiation characteristics in K562 cells. Cell Transplant, 2003,12 (4): 365-377.
  • 8Elbashir S M, Lendeckel W, Tuschl T. RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev,2001,15(2): 188-200.
  • 9Zamore P D. Ancient pathways programmed by small RNAS. Science,2002,296(5571 ): 1265-1269.
  • 10Martinez J, Patkaniowska A, Urlaub H, et al. Single-stranded antisence siRNAs guide target RNA cleavage in RNAi. Cell,2002,110(5):563-574.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部